Great post! This goes right to the heart of how it is truly impossible it is for anyone but a professional analysts (with access to accurate market data of all current psoriasis drugs and OTC treatments) to make an accurate estimation of the EPS for $OWCP in Q3 and Q4.
We still don't know how much is coming in from the 3 consulting contracts. We don't know if they will be selling generic OTC creams for things like acne. Really looking forward to clarification in future 8-Ks.